Cargando…
The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes
(1) Background: In an adult skeleton, bone is constantly renewed in a cycle of bone resorption, followed by bone formation. This coupling process, called bone remodeling, adjusts the quality and quantity of bone to the local needs. It is generally accepted that osteoporosis develops when bone resorp...
Autores principales: | Siegenthaler, Barbara, Ghayor, Chafik, Gjoksi-Cosandey, Bebeka, Ruangsawasdi, Nisarat, Weber, Franz E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275050/ https://www.ncbi.nlm.nih.gov/pubmed/30366476 http://dx.doi.org/10.3390/ijms19113332 |
Ejemplares similares
-
The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model
por: Gjoksi, Bebeka, et al.
Publicado: (2016) -
N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment
por: Ghayor, Chafik, et al.
Publicado: (2017) -
The Release of the Bromodomain Ligand N,N-Dimethylacetamide Adds Bioactivity to a Resorbable Guided Bone Regeneration Membrane in a Rabbit Calvarial Defect Model
por: Siegenthaler, Barbara, et al.
Publicado: (2020) -
Effect of N-Vinyl-2-Pyrrolidone (NVP), a Bromodomain-Binding Small Chemical, on Osteoblast and Osteoclast Differentiation and Its Potential Application for Bone Regeneration
por: Klemmer, Viviane A., et al.
Publicado: (2021) -
Fibrin Hydrogel Based Bone Substitute Tethered with BMP-2 and BMP-2/7 Heterodimers
por: Karfeld-Sulzer, Lindsay S., et al.
Publicado: (2015)